Navigation Links
ADVENTRX Pharmaceuticals Announces Financing
Date:6/8/2009

SAN DIEGO, June 8 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has obtained a commitment to purchase shares of convertible preferred stock pursuant to a registered direct offering to a single institutional investor, representing gross proceeds of approximately $2 million. The preferred stock is convertible into shares of ADVENTRX's common stock at the option of the investor at a price of $0.1105 per share.

The investor will also receive warrants to purchase 8,116,290 shares of ADVENTRX's common stock. The warrants have an exercise price of $0.15 per share and are exercisable at any time after the six-month anniversary of the closing of the transaction and before the fifth anniversary of such initial exercise date. The closing of the offering is expected to take place on or before June 12, 2009, subject to the satisfaction of customary closing conditions. ADVENTRX plans to use the net proceeds from the offering to fund activities related to seeking FDA approval to market ANX-530 (vinorelbine emulsion) in the United States, including manufacturing-related activities, and for general corporate purposes, including general and administrative expenses.

The shares and warrants are being offered by ADVENTRX pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ("SEC"). A prospectus supplement relating to the offering will be filed with the SEC. Rodman & Renshaw, LLC, a wholly owned subsidiary of Rodman & Renshaw Capital Group, Inc. (NasdaqGM: RODM), acted as the exclusive placement agent for the transaction.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state or jurisdiction in which such offer, solicitation or sa
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results
2. ADVENTRX Announces Further Cost-Cutting Measures
3. ADVENTRX Provides Update on Strategic Transaction Process
4. ADVENTRX Announces Further Cost-Cutting Measures
5. ADVENTRX Exploring Strategic Options
6. ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update
7. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Global Healthcare Conference
8. ADVENTRX Announces Restructuring and Cost Reduction Initiatives
9. ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
10. ADVENTRX Settles Dispute With Former Licensee
11. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Atomic Force Microscopy (AFM) have been developed and are opening ... liquid/air interface. The NeedleProbes’ cylindrical geometry enables researchers to ... viscosity - all in a single force distance curve. ... ... New, constant diameter NeedleProbes are enabling unique measurements ...
(Date:12/15/2009)... BRIARCLIFF MANOR, N.Y., Dec. 15 The ... announced that the professional society is continuing to ... is being held in Arlington, VA, April 19-21, ... society is encouraging non-members to join the organization ... event. The submission deadline is 12 AM EST, ...
(Date:12/15/2009)... Dec. 15 On January 20th, 2010, ... for Medical Publication Professionals (ISMPP) will be held ... UK. More than 100 attendees are expected at ... publication professionals, editors, publishers, medical writers and medical ... publications and the impact of guidelines and regulations ...
(Date:12/15/2009)... - 45 Patients Enrolled ... Cells to Restore Cardiac Function ,, ... company specialising,in cell-based therapies for the treatment of ... months ahead of schedule,enrolment in the first stage ... a,unique stem cell therapy for heart failure. Forty-five ...
Breaking Biology Technology:New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 2The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3
... ADHD ages 6 to 65, RARITAN, N.J., June ... behavioral disorder treated in children(1), and,according to the National ... percent of children with ADHD continue to exhibit symptoms,in ... eight million, or,one in 20, adults in the United ...
... VIAP ), a biotechnology company focused on the ... join the,Russell Microcap Index when Russell Investments reconstitutes its ... according to a preliminary list,of additions posted on ... selected for inclusion in this objective,market-driven index as we ...
... The Spanish flu outbreak of 1918 killed between 30 ... ultimate cause of death was acute respiratory distress syndrome ... the body during which the lung becomes severely damaged. ... infections, but also by chemical agents. These could be ...
Other Biology Technology:FDA Approves CONCERTA(R) (methylphenidate HCI) Extended-release Tablets for Treatment of ADHD (Attention Deficit Hyperactivity Disorder) in Adults 2FDA Approves CONCERTA(R) (methylphenidate HCI) Extended-release Tablets for Treatment of ADHD (Attention Deficit Hyperactivity Disorder) in Adults 3FDA Approves CONCERTA(R) (methylphenidate HCI) Extended-release Tablets for Treatment of ADHD (Attention Deficit Hyperactivity Disorder) in Adults 4VIA Pharmaceuticals Set to Join Russell Microcap Index 2VIA Pharmaceuticals Set to Join Russell Microcap Index 3VIA Pharmaceuticals Set to Join Russell Microcap Index 4New strategies against bird flu 2
(Date:12/16/2009)... DigitalPersona, Inc., a leader in ... an agreement with IBM to deploy a ... technology on IBM SurePOS 500 retail systems. ... applications to more easily and quickly identify ... linked to the individuals who perform them. ...
(Date:12/16/2009)... BIO-key International, Inc. (OTC Bulletin ... safety and finger-based biometric identification solutions, announced ... a Special Shareholder Meeting held today approved ... Division to Interact911 Mobile Systems Inc. Of ... favor and 1.2% were opposed. ,, (Logo: ...
(Date:12/16/2009)... Texas, Dec. 8, 2009 National ... in industrial measurement and control, and DENSO ... automation using robotics technology, today announced their ... technology with DENSO robotic arms. The collaboration ... research and flexible manufacturing applications. In today,s ...
Breaking Biology News(10 mins):DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 4National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 5Free Braces Screening Exam Day June 19 49421 1Free Braces Screening Exam Day June 19 49421 2Swine Flu Outbreak at Miami Immigration Center to be Discussed on AFGE Radio Show 49418 1Swine Flu Outbreak at Miami Immigration Center to be Discussed on AFGE Radio Show 49418 2Work Stress for Mom Might Harm Baby 49415 1
... Hopkins have figured out how one particular protein contributes to ... an hour or two. The findings are reported in two ... protein, called Arc, has been implicated in memory-linked behaviors ranging ... 3-D space. In people, Arc may be one culprit behind ...
... first time, scientists have engineered yeast cells capable ... proteins with fully human sugar structures (glycosylation). These ... half-life and to date, have necessitated the expression ... reported today has the potential to eliminate the ...
... life's first cells, Irene Chen, a regional winner from ... to receive the $25,000 GE & Science Prize for Young ... Science , which is published by AAAS, the nonprofit society. ... Monday, 11 December, during an award ceremony. She will also ...
Other Biology News:Hopkins researchers discover how brain protein might control memory 2Hopkins researchers discover how brain protein might control memory 3GlycoFi and Dartmouth report full humanization of yeast glycosylation pathway in Science 2American scientist's research of life's first cells 2American scientist's research of life's first cells 3American scientist's research of life's first cells 4
... ReadyPrep overlay agarose, is a low ... sample setup to secure IPG strips in ... dye is incorporated to allow monitoring of ... 0.5% low melting point agarose in 1x ...
Criterion staining and blotting trays are plastic trays designed for staining one or two Criterion gels or performing western blot detection. The trays have a working capacity of up to 500 ml. Suppli...
... a wide range of next-generation features into ... new standard for flexible laboratory solutions. It ... including pipetting, dilution, dispensing, and integrations ... powerful and flexible as it is efficient ...
These Costar 96-well, flat-bottom polystyrene EIA plates are used for EIAs, ELISAs, and other protein binding assays. Supplied as box of 100 (20 packages; 5 plates per package)....
Biology Products: